ARRY three-lens brief
Evidence-based stock research on ARRY. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price up 9.94% in the last session — a material single-day move. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Price up 9.94% in the last session — a material single-day move.
- Outperforming SPY by 29.4pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $6.95 — 34% above current (19 analysts).
- Debt-to-equity of 252% — balance-sheet-heavy.
ARRY closed at $5.20 (+9.94%) as of 2026-11-12. Market cap: $802.20M. Price is above the 50-day MA and below the 200-day MA. Positives: price up 9.94% in the last session — a material single-day move.; outperforming SPY by 29.4pp over 30 days.. Concerns: currently unprofitable on a trailing basis — no P/E multiple available.; debt-to-equity of 252% — balance-sheet-heavy.. Last quarter: Revenue $330.21M, net income -$7.92M, free cash flow $125.53M.
Why three lenses on ARRY, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARRY across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ARRY" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARRY brief"></iframe>